Sharon E. Underberg - 13 Feb 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
EVP, GC & Corporate Secretary
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
Issuer symbol
IDXX
Transactions as of
13 Feb 2025
Net transactions value
-$97,352
Form type
4
Filing time
18 Feb 2025, 21:44:07 UTC
Previous filing
20 Feb 2024
Next filing
12 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Award $0 +137 +2.4% $0.000000 5,779 14 Feb 2025 Direct F1
transaction IDXX Common Stock Award $0 +173 +3% $0.000000 5,952 14 Feb 2025 Direct
transaction IDXX Common Stock Award $0 +176 +3% $0.000000 6,128 14 Feb 2025 Direct
transaction IDXX Common Stock Award $0 +218 +3.6% $0.000000 6,346 14 Feb 2025 Direct
transaction IDXX Common Stock Tax liability $97,352 -219 -3.5% $444.53 6,127 14 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +4,504 $0.000000 4,504 13 Feb 2025 Common Stock 4,504 $459.76 Direct F2
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.000000 217 13 Feb 2025 Common Stock 217 $459.76 Direct F3
transaction IDXX Restricted Stock Unit Award $0 +1,060 $0.000000 1,060 13 Feb 2025 Common Stock 1,060 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -137 -100% $0.000000 0 14 Feb 2025 Common Stock 137 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -173 -50% $0.000000 173 14 Feb 2025 Common Stock 173 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -176 -33% $0.000000 352 14 Feb 2025 Common Stock 176 Direct F7
transaction IDXX Restricted Stock Unit Options Exercise $0 -218 -25% $0.000000 652 14 Feb 2025 Common Stock 218 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 30, 2024 and December 31, 2024.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F4 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.